The global burn care market size is expected to reach USD 4.23 billion by 2030, expanding at a CAGR of 7.18% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing incidences of burn injuries are anticipated to fuel the demand for cost-effective treatment over the forecast period. For instance, according to NIH report (published in 2022) about 450,000 patients received treatment for burns annually, and about 30,000 require admission to burn centers.
As per the same source, 96.0% of fatal fire-related burns occur in low to middle-income countries. According to the data published by the NIH, on average, 265,000 deaths are caused by burns every year. The majority of these deaths occur in low to middle-income countries and half of them occur in South East Asia. Moreover, around 1,000,000 people in India are moderately or severely burnt and around 173,000 children in Bangladesh are burnt each year.
It also reported that in the U.S., approximately 4,500 burn victims die annually and 10,000 die due to burn-related infections. Owing to this substantial increase in the number of burn incidences, the patient population for burn care and treatment has increased. This, in turn, is expected to drive market growth over the forecast period. Furthermore, due to the rising incidences of burns, the demand for treatment options is increasing and as a result, the overall healthcare expenditure on burn care is increasing.
Treatment options for burn care include advanced dressings, biologics, traditional burn care products, and others. The foam dressings developed from semipermeable polyurethane are waterproof and can be used on heavily exuding wounds. As a result of which they are preferred over normal dressings which are not waterproof and need to be changed regularly.
Request a free sample copy or view report summary: Burn Care Market Report
The advanced dressing segment was identified as the highest revenue generator with 42.54% share in 2023.
In 2023, full-thickness burns led the burn care market, holding the highest revenue share of 39.89%. A report from WHO in October 2023 highlighted that burns are responsible for around 180,000 deaths annually. The market growth is further propelled by the increasing efforts of both governmental and non-governmental organizations focused on burn care treatments.
In 2023, thermal burns held the highest revenue share at 74.79%, driven by the prevalent instances of fire burn. The American Burn Association (ABA) notes that fire burn accounts for 44.0% of admissions to burn centres.
The hospitals segment accounted for the largest revenue share in 2023, owing to the rising incidence of burns and consequent hospitalizations every year.
North America dominated the market with the largest revenue share of 51.56% in 2023. This dominance can be attributed to the rising awareness among people about burn treatment options and increasing disposable income.
Grand View Research has segmented global burn care market report based on product, depth of burn, cause, end-use, and region:
Burn Care Product Outlook (Revenue, USD Million, 2018 - 2030)
Advanced Dressing
Alginate Dressings
Collagen Dressings
Hydrogel Dressings
Hydrocolloid Dressings
Wound Contact Layers
Film Dressings
Foam Dressings
Biologics
Traditional Burn Care Products
Others
Burn Care Depth Of Burn Outlook (Revenue, USD Million, 2018 - 2030)
Minor Burns
Partial Thickness Burns
Full Thickness Burns
Burn Care Cause Outlook (Revenue, USD Million, 2018 - 2030)
Thermal Burns
Electrical Burns
Radiation Burns
Chemical Burns
Friction Burns
Burn Care End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Outpatient Facilities
Home Care
Research & Manufacturing
Burn Care Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Burn Care Market
3M
Hollister Incorporated
Cardinal Health
Integra LifeSciences Corporation
Coloplast Corp.
DeRoyal Industries, Inc.
Smith & Nephew
ConvaTec Inc.
Mölnlycke Health Care AB.
Johnson & Johnson
"The quality of research they have done for us has been excellent..."